Bessemer Group Inc. acquired a new position in shares of Clarivate PLC (NYSE:CLVT – Free Report) during the first quarter, HoldingsChannel.com reports. The fund acquired 7,601 shares of the company’s stock, valued at approximately $30,000.
A number of other hedge funds and other institutional investors also recently modified their holdings of CLVT. Clarkston Capital Partners LLC lifted its stake in shares of Clarivate by 8.1% in the fourth quarter. Clarkston Capital Partners LLC now owns 70,733,831 shares of the company’s stock worth $359,328,000 after acquiring an additional 5,319,535 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in shares of Clarivate by 53.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 27,776,892 shares of the company’s stock worth $141,107,000 after acquiring an additional 9,691,104 shares in the last quarter. Thompson Siegel & Walmsley LLC lifted its stake in shares of Clarivate by 14.4% in the fourth quarter. Thompson Siegel & Walmsley LLC now owns 10,498,588 shares of the company’s stock worth $53,333,000 after acquiring an additional 1,323,329 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of Clarivate by 6.6% in the fourth quarter. Vanguard Group Inc. now owns 8,750,858 shares of the company’s stock worth $44,454,000 after acquiring an additional 538,907 shares in the last quarter. Finally, Invenomic Capital Management LP lifted its stake in shares of Clarivate by 11.3% in the fourth quarter. Invenomic Capital Management LP now owns 6,585,707 shares of the company’s stock worth $33,455,000 after acquiring an additional 667,146 shares in the last quarter. Institutional investors and hedge funds own 85.72% of the company’s stock.
Insider Transactions at Clarivate
In other Clarivate news, insider James Gordon Samson sold 100,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $4.53, for a total transaction of $453,000.00. Following the sale, the insider owned 1,271,103 shares in the company, valued at $5,758,096.59. This represents a 7.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 23.18% of the stock is owned by insiders.
Analyst Ratings Changes
Get Our Latest Stock Report on CLVT
Clarivate Trading Down 1.7%
NYSE:CLVT opened at $4.38 on Friday. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.88 and a current ratio of 0.88. Clarivate PLC has a one year low of $3.04 and a one year high of $7.15. The business’s 50-day simple moving average is $4.27 and its 200 day simple moving average is $4.42. The stock has a market cap of $2.99 billion, a price-to-earnings ratio of -4.51 and a beta of 1.47.
Clarivate (NYSE:CLVT – Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.02. Clarivate had a positive return on equity of 8.75% and a negative net margin of 26.32%. The firm had revenue of $593.70 million for the quarter, compared to analysts’ expectations of $574.03 million. During the same quarter in the prior year, the firm posted $0.14 earnings per share. Clarivate’s revenue for the quarter was down 4.4% compared to the same quarter last year. As a group, sell-side analysts predict that Clarivate PLC will post 0.63 earnings per share for the current fiscal year.
Clarivate Profile
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Recommended Stories
- Five stocks we like better than Clarivate
- Most active stocks: Dollar volume vs share volume
- The Apple Comeback Will Be Better Than the Setback
- Stock Market Upgrades: What Are They?
- How a Government Loan Changes the Game for Plug Power
- How to Short Nasdaq: An Easy-to-Follow Guide
- Qualcomm’s Hold Rating Misses Strong Growth Story
Want to see what other hedge funds are holding CLVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clarivate PLC (NYSE:CLVT – Free Report).
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.